Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11851659 Compositions and methods for immunooncology

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 27 Dec, 2023
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 27 Dec, 2023
Edits made to:
Infobox (+73 properties)
Article (+117 characters)
‌

 US Patent 11851659 Compositions and methods for immunooncology

Article

Patent abstract

The present disclosure is directed to genome editing systems, reagents and methods for immunooncology.

Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118516590
Patent Inventor Names
Hyungwook Lim0
Jennifer Brogdon0
Ming-Wei Chen0
Morag Stewart0
Sarah Hesse0
Yi Yang0
Date of Patent
December 26, 2023
0
Patent Application Number
164983610
Date Filed
March 21, 2018
0
Patent Citations
‌
US Patent 7265209 CE7-specific chimeric T cell receptor
0
‌
US Patent 7319143 Genetically-engineered MHC molecules
0
‌
US Patent 7320787 Redirection of cellular immunity by protein tyrosine kinase chimeras
0
‌
US Patent 7446190 Nucleic acids encoding chimeric T cell receptors
0
‌
US Patent 7446191 DNA construct encoding CE7-specific chimeric T cell receptor
0
‌
US Patent 7514537 Chimeric immunoreceptor useful in treating human gliomas
0
‌
US Patent 7638326 Activation and expansion of T-cells using an engineered multivalent signaling platform
0
‌
US Patent 7741465 Chimeric receptor genes and cells transformed therewith
0
‌
US Patent 7745140 Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
0
‌
US Patent 7754482 Artificial antigen presenting cells and uses therefor
0
‌
US Patent 7994298 Chimeric NK receptor and methods for treating cancer
0
‌
US Patent 8211422 Chimeric receptor genes and cells transformed therewith
0
‌
US Patent 8252914 Chimeric NK receptor and methods for treating cancer
0
‌
US Patent 8389282 Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
0
‌
US Patent 8399645 Chimeric receptors with 4-1BB stimulatory signaling domain
0
‌
US Patent 8465743 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
0
‌
US Patent 8637307 Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
0
‌
US Patent 8722400 Artificial antigen presenting cells and uses therefor
0
‌
US Patent 8906682 Methods for treatment of cancer
0
‌
US Patent 8911993 Compositions for treatment of cancer
0
‌
US Patent 8916381 Methods for treatment of cancer
0
‌
US Patent 8975071 Compositions for treatment of cancer
0
‌
US Patent 9101584 Methods for treatment of cancer
0
‌
US Patent 9102760 Compositions for treatment of cancer
0
‌
US Patent 9102761 Compositions for treatment of cancer
0
‌
US Patent 9272002 Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
0
‌
US Patent 9328156 Use of chimeric antigen receptor-modified T cells to treat cancer
0
‌
US Patent 9365641 Compositions and methods for targeting stromal cells for the treatment of cancer
0
‌
US Patent 9394368 Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
0
‌
US Patent 9402865 Compositions and methods for treating cancer
0
‌
US Patent 9422351 Isolated B7-H4 specific compositions and methods of use thereof
0
‌
US Patent 9446105 Chimeric antigen receptor specific for folate receptor β
0
‌
US Patent 9464140 Compositions and methods for treatment of cancer
0
‌
US Patent 9481728 Compositions and methods for treatment of cancer
0
‌
US Patent 9499629 Use of chimeric antigen receptor-modified T-cells to treat cancer
0
‌
US Patent 9518123 Compositions and methods for treatment of cancer
0
‌
US Patent 9540445 Compositions and methods for treatment of cancer
0
‌
US Patent 9572836 Methods for assessing the suitability of transduced T cells for administration
0
‌
US Patent 9573988 Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells
0
‌
US Patent 9598489 Human alpha-folate receptor chimeric antigen receptor
0
‌
US Patent 9708384 Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
0
‌
US Patent 9714278 Use of ICOS-based CARs to enhance antitumor activity and CAR persistence
0
‌
US Patent 9745368 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
0
‌
US Patent 9765156 Enhancing activity of CAR T cells by co-introducing a bispecific antibody
0
‌
US Patent 9777061 Treatment of cancer using a CD33 chimeric antigen receptor
0
‌
US Patent 9815901 Treatment of cancer using a CD123 chimeric antigen receptor
0
‌
US Patent 9999671 Delivery of negatively charged proteins using cationic lipids
0
‌
US Patent 10689438 Stable protein solution formulation containing high concentration of an anti-VEGF antibody
0
‌
US Patent 7049136 Redirection of cellular immunity by receptor chimeras
0
‌
US Patent 7052906 Synthetic transmembrane components
0
‌
US Patent 7070995 CE7-specific redirected immune cells
0
Patent Primary Examiner
‌
Kevin K Hill
0
CPC Code
‌
C12N 2310/20
0
‌
C12N 15/86
0
‌
C12N 15/1138
0
‌
C07K 14/70578
0
‌
C07K 14/70503
0
‌
C12N 2800/80
0
‌
C12N 9/22
0
‌
C07K 2319/33
0
‌
C07K 2319/30
0

Find more entities like US Patent 11851659 Compositions and methods for immunooncology

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.